TG Therapeutics Inc (NASDAQ:TGTX)

Delayed Data
As of Jan 28
 +0.98 / +7.45%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 24.00, with a high estimate of 39.00 and a low estimate of 16.00. The median estimate represents a +69.73% increase from the last price of 14.14.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 39.49%
Growthannually 12.87%


Growthquarterly 0.00%
Growthannually 19.47%
Key to the earnings and sales forecast charts.